Memorial Sloan-Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.

New studies investigate how the use of antibiotics affects the balance of both harmful and beneficial bacteria in patients undergoing stem cell transplantation.

A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.

After signing up for the National Bone Marrow Registry “Be The Match,” a Montclair man was recently called to donate peripheral blood stem cells for a sick child. He was inspired to join the registry after an anonymous donor saved the life of his own son, who had received a bone marrow transplant.